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Purpose: Hybrid positron emission tomography PET/magnetic resonance MR imaging systems
have recently been built that allow functional and anatomical information obtained from PET and
MR to be acquired simultaneously. The authors have developed a robust coregistration scheme for
a first generation small animal PET/MR imaging system and illustrated the potential of this system
to study intratumoral heterogeneity in a mouse model.
Methods: An alignment strategy to fuse simultaneously acquired PET and MR data, using the MR
imaging gradient coordinate system as the reference basis, was developed. The fidelity of the
alignment was evaluated over multiple study sessions. In order to explore its robustness in vivo, the
alignment strategy was applied to explore the heterogeneity of glucose metabolism in a xenograft
tumor model, using 18F-FDG-PET to guide the acquisition of localized 1H MR spectra within a
single imaging session.
Results: The alignment method consistently fused the PET/MR data sets with subvoxel accuracy
registration error mean=0.55 voxels, 0.28 mm; this was independent of location within the
field of view. When the system was used to study intratumoral heterogeneity within xenograft
tumors, a correlation of high 18F-FDG-PET signal with high choline/creatine ratio was observed.
Conclusions: The authors present an implementation of an efficient and robust coregistration
scheme for multimodal noninvasive imaging using PET and MR. This setup allows time-sensitive,
multimodal studies of physiology to be conducted in an efficient manner. © 2010 American Asso-
ciation of Physicists in Medicine. DOI: 10.1118/1.3369447
Key words: magnetic resonance imaging MRI, positron emission tomography PET, hybrid
systems, small animal imaging, in vivo biological monitoringI. INTRODUCTION
Noninvasive, multimodal imaging is increasingly being
adopted for both clinical and preclinical studies, as research-
ers realize that information available from different image
contrasts can complement each other to provide more in-
sights into physiological processes of intact, living
animals.1–5 The most prominent example of this has been the
widespread adoption of combined positron emission tomog-
raphy PET and computed tomography CT systems. Ana-
tomical information from the CT has been very useful in
giving context to the PET image, especially in oncology
research.6–9 In both clinical and small animal PET/CT sys-
tems, a combination of careful hardware alignment along
with image registration via fiducial markers, phantoms,
and/or matching of expected uptake patterns in the two im-
ages allows accurate spatial fusion of PET and CT
images.10–13
Magnetic resonance MR imaging is another imaging
modality widely used for noninvasive, in vivo imaging. It can
1995 Med. Phys. 37 „5…, May 2010 0094-2405/2010/37„5…/provide high resolution, soft tissue details, along with func-
tional and metabolic information via techniques such as
blood oxygenation level dependent BOLD imaging,14
diffusion,15 and spectroscopy.16 Recognizing the comple-
mentary nature of PET and MR information, especially the
utility of the information from multimodal images acquired
simultaneously,17 researchers have developed hardware for
hybrid PET/MR systems. Approaches range from MR-
compatible PET systems using avalanche photodiode APD
technology for simultaneous PET/MR imaging,18,19 a split
magnet that can house current state of the art PET detector
systems,20 to field-cycling approaches that allow PET and
MR images to be obtained sequentially.21
As the combined PET/MR technology matures, it is nec-
essary to develop techniques and imaging strategies that
maximize the capabilities of such systems to study interest-
ing and novel biological and clinical questions. An important
consideration for multimodal systems is a robust method to
merge individual data sets. For small animal PET/CT sys-
tems, significant efforts are devoted to ensure good intermo-
19951995/9/$30.00 © 2010 Am. Assoc. Phys. Med.
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of PET and CT visible fiducial markers are imaged with the
animal to allow retrospective image registration.10,13 Alterna-
tively, a registration transform is defined between the fields
of view FOVs of the PET and CT scanners through judi-
cious design of PET/CT phantoms that span the FOV of both
systems, coupled with a reproducible method to position
physically the animal holder in both FOVs.12
Conceivably, one can adopt similar alignment approaches
for PET/MR systems. Two main issues need to be considered
specifically in PET/MR systems for spatial alignment pur-
poses. First, the geometry is more constrained in PET/MR
than for PET/CT setups. The typical ring diameter for a com-
mercial small animal PET/CT is 15 cm or greater, com-
pared to 6 cm for the current APD-based PET/MR
inserts.19,22 The animal subject, radiofrequency RF coil,
and physiological maintenance and monitoring devices need
to fit inside this ring. Moreover, to maximize signal to noise
ratio SNR for MR images, it is often desirable to position
the excite/receive RF coils close to the animal. All these
factor limit the imaging of fiducial markers concurrently
with an animal without specialized invasive approaches.23
Second, the FOV of the MR is not fixed between scans. An
advantage of MR imaging is the flexibility to alter the FOV
geometry and resolution of the acquired data depending on
the biological region of interest ROI within the animal. For
example, fMRI BOLD imaging in monkeys and humans of-
ten use oblique brain slices to isolate specific functional
brain areas; cardiovascular imaging applications may need
oblique slices to image structures such as the aortic arch;
while dynamic MRI scans may require a tight FOV to obtain
sufficient spatial and time resolution. In such cases, we can-
not determine the MR imaging FOV a priori to facilitate
direct PET to MR image alignment. For the purposes of flex-
ible simultaneous PET/MR imaging, we require a reliable
strategy to efficiently determine the intersection of the PET
and MR FOVs for all scans during the imaging session. Sub-
sequent to the imaging, we also require a method to register
the reconstructed PET/MR images to form a multimodal data
set.
In a previous study, Judenhofer et al.19 showed that fusion
of individual simultaneous PET and MR phantom images
using a rigid body transform is possible using an APD-based
PET/MR system, with the registration error on the PET/MR
image sets after transformation within the spatial resolution
of the PET system. This suggests that APD-based PET sys-
tems produce images that can be aligned consistently to the
MR data sets. In this paper, we extend this observation to
develop and evaluate an efficient acquisition and processing
setup of simultaneously acquired PET/MR data using a po-
sition sensitive APD-based, small animal MR-compatible
PET insert. The setup ensures robust spatial alignment of the
PET and MR images by first aligning the PET FOV and a
fixed MR FOV using a PET/MR visible phantom. The reg-
istration accuracy of using a single PET to fixed MR FOV
registration for the alignment of images from multiple study
sessions was then evaluated. Further, we describe an algo-
rithm to relate multiple MR FOVs to the fixed MR FOV and
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responsible for spatial encoding of images remain fixed
throughout all studies. Using the described setup, PET/MR
information was acquired in real-time to follow the func-
tional and metabolic status of the in vivo tumor microenvi-
ronment. Moreover, we show that the setup allows one mo-
dality to guide studies with the other within a single imaging
session.
II. MATERIALS AND METHODS
II.A. MR-compatible PET insert for simultaneous PET/
MR studies
Studies were done using a MR-compatible PET insert.
The insert consists of a concentric ring of 16 lutetium oxy-
orthosilicate LSO scintillators and position-sensitive ava-
lanche photodiodes PSAPDs detector modules. The intact
system is designed to fit within the bore of a Bruker Biospin
7T magnet fitted with a Bruker B-GA12 gradient coil set 12
cm i.d., 40 G/cm maximum, 0.2 G cm Å. The FOV offered
by this PET setup is 35.3535.3512 mm3. Previous re-
ports demonstrated little to no interference between the PET
and MRI electronics enabling PET and MRI images to be
obtained at the same time.18 PET data were acquired using
in-house developed software,24 while the MR console was
run by PARAVISION Bruker Biospin Inc., Billerica, MA soft-
ware. Since the gain of the PSAPD detectors is temperature
dependent, the detectors were kept at −12.5 °C for all stud-
ies using a continuous flow of chilled dried air.
II.B. PET/MR image alignment
We explored whether alignment using an external phan-
tom can give accurate registration over the course of a
study day, as well as over multiple days. An “alignment”
phantom consisting of rods filled with 50 Ci
18F-fluorodeoxyglucose FDG solution was imaged simulta-
neously with both PET and MR. The rods used were glass
capillary tubes OD / ID=1.2 /0.68 mm sealed at the ends
with tube sealer Becton Dickenson, Franklin Lakes, NJ. A
model of the alignment phantom is shown in Fig. 1a. For
all PET studies, counts were acquired over 300 s and recon-
25
FIG. 1. PET/MR FOV alignment phantom. a Rendering of PET/MR phan-
tom. The phantom consisted of five rods, three in the z-direction for xy plane
alignment and two parallel to the xy plane for z slice alignment. The latter
are spaced 5 mm apart. The rods were filled with 18F-FDG solution. b
PET/MR phantom image overlay. MR image rendering is given as narrow
rendered objects black; PET image rendering is wrapped around the MR
rods light grey.structed with a maximum a posteriori algorithm to a matrix
1997 Ng et al.: A robust coregistration for in vivo PET/MR 1997size of 12812815 and a pixel size of 0.2760.276
0.754 mm3. MRI images were obtained with a 2D-spoiled
gradient echo FLASH sequence TR /TE=350 /4 ms with
a matrix size of 128128, and 40 contiguous slices resulting
in a pixel size equivalent to that of the PET images. The
FOV of the MR 35.3535.3525.6 mm3 is larger than
the PET 35.3535.3512.8 mm3 to ensure that the
whole PET FOV is captured by the MR FOV and hence
allow proper alignment between the two image bases. This
MR FOV is denoted hereafter as the home FOV, FOVhome.
Setting the FOVhome as the reference basis, a semi-automatic
alignment procedure was adopted to match the two spaces.
First, the rod phantoms along the z direction axial were
matched manually between the PET and MR images. As the
spatial resolution of the PET along the axial direction as well
as the outer diameter of the rods themselves dictate that one
rod in the alignment phantom will traverse multiple PET
slices, the central slice of the rod in both PET and MR was
used to match the two bases along the z direction. The cen-
troid of the rod cross-sections perpendicular to the z direction
served as inputs for alignment in the xy plane. Voxels within
five voxels of the local maximum and with intensity above
20% of the local maximal intensity were considered in a
center of mass calculation of each centroid. Points were fed
into a least-squares 2D affine transformation algorithm
implemented in MATLAB.26 These two steps combine to de-
rive a 3D affine transformation matrix. This matrix obtained
at the beginning of the imaging session was stored and used
for all subsequent image alignment. We measured the cen-
troid registration error between the MR images and trans-
formed PET images of the alignment phantom using the
same transformation matrix over the course of a single day of
imaging as well as over several days of imaging, with the
centroid of the rod cross-sections on multiple image slices as
the metric. The alignment phantom was unloaded and loaded
between these scans to simulate a normal in vivo imaging
session day.
To estimate the positioning accuracy of this alignment
scheme as a function of location within the FOV, a phantom
consisting of glass capillaries OD / ID=0.85 /0.4 mm, filled
with 50 Ci FDG diluted in 0.05 M Prohance, and located
0, 4, 8, and 12 mm radially from the center of the FOV was
imaged simultaneously with PET/MR and aligned using an
independently determined transformation matrix derived as
above, using the alignment phantom shown in Fig. 1a.
PET/MR images of this phantom are shown in Figs.
2a–2c. The centroid registration error as a function of
distance from the center of the FOV was then evaluated as
above. One-way ANOVA analysis was used to evaluate
whether there were significant differences in registration be-
tween rods at different locations within the PET FOV. In
Supplemental Material Section I,27 we compare the align-
ment accuracy between images acquired with different MRI
pulse sequences, with and without the PET insert, demon-
strating good geometric matching between images taken with
different sequences, also with and without the PET insert. In
27Supplemental Material Section II, we compare the align-
Medical Physics, Vol. 37, No. 5, May 2010ment accuracy between images registered with different
transformations, showing that registration with the affine
transformation is slightly better than using the rigid body
transform.
The fidelity of this registration scheme was further tested
with a third phantom and 18F-FDG studies on mice contain-
ing small subcutaneous tumors MC-38.CEA colorectal ad-
enocarcinoma. Experiments involving the use of animals
were done in accordance with protocols approved by the
Animal Care and Use Committee of the California Institute
of Technology.
II.C. Alignment of multiple MR FOVs
Often it is advantageous to optimize the orientation and
size of the MRI FOV to accommodate a specific imaging
goal. For simultaneous PET/MR imaging, care needs to be
taken to ensure that the alternate MR FOV FOValt overlaps
adequately with the PET FOV for the desired region of in-
terest. For quick visualization of the PET and MR FOVs
during an imaging session, we use the geometry defined by
the MRI metadata to generate Cartesian coordinates of the
centroids and vertices for each voxel of both the PET FOV
and the alternate MR FOV. These values are used to visualize
the “bounding box” of both FOVs in the same coordinate
system, which allows a quick determination of the suitability
of the FOValt for PET/MR imaging.
To generate aligned PET/MR data sets, the PET image
registered to FOVhome, as described in Sec. II B, is first
resliced to an isotropic voxel size of 0.2760.276
3
FIG. 2. PET/MR FOV alignment strategy registers other phantom sets ro-
bustly. a–c Structured phantom used to evaluate alignment accuracy as a
function of location within the FOV. Rods were located at 0, 4, 8, and 12
mm from the center of the PET/MR FOV. Alignment accuracy was evalu-
ated after registration using a transformation derived from the alignment
phantom. a MR image of the phantom. b PET image of the phantom. c
Fused data set. A large circular water phantom, shown as the large circle in
a and c, was inserted into the phantom to facilitate shim, frequency, and
gain adjustments of the MR. One capillary rod was filled with water only
and thus was visualized in the MR but not in PET arrow. d–f The
transform derived to form the overlay in Fig. 1b was used to fuse an image
containing an alternative phantom arrangement. f Fused PET/MR image of
a seven rod phantom shows the fidelity of the transform. Scale bars
=10 mm.0.276 mm . It then undergoes a rigid body transformation
1998 Ng et al.: A robust coregistration for in vivo PET/MR 1998using the transformation matrix from MRI metadata, and
subsequently resliced to the voxel size of the alternate MR
FOV. The whole data stream is implemented in MATLAB; a
trilinear interpolation is used for all rotations and reslicing.
To demonstrate the feasibility of this method, we simu-
lated the mapping on phantom images using different geom-
etries that we typically encounter in our studies. An oblique
slicing simulating an acquisition along an aortic vessel and a
geometry that is offset and sampled at a different matrix size
than the home FOV were aligned with simultaneously ac-
quired PET data. This method was also used to remap a PET
data set to a mouse anatomical reference image.
II.D. Biological studies with PET/MR: A real-time
feedback scheme
TgCEA+C57BL /6 mice N=2 were implanted with
MC-38.CEA colorectal adenocarcinoma cells in the groin
and shoulder seven days prior to imaging. Mice were fasted
8–12 h prior to the imaging session to minimize extraneous
18F-FDG signals. One hour prior to the imaging session,
each mouse was injected intraperitoneally with 200 Ci
18F-FDG. The mouse was then placed in the PET/MRI sys-
tem and kept at 37 °C with warm air blowing through the
RF coil and anesthetized using 1.5% isofluorane mixed in air.
The holder was designed in such a way that the mouse was
kept comfortable while the PET insert remained stable at its
operating temperature. Using the known alignment matrix,
we shifted the expected region of functional interest, in this
case the tumor, within the PET FOV using the motorized
stage. Once aligned, high resolution anatomical MRI 2D
RARE TR /TE=3500 /4.5 ms, matrix size=12812834,
resolution=0.2760.2760.754 mm3 and PET 300 s du-
ration scans were obtained simultaneously. Both PET and
MR images were respiratory-gated to acquire data during the
expiration phase.
Alignment time per PET data set was 5–15 min AMD,
4 Dual-Core Opteron 885 2.6 GHz, 32 GB memory. This
relatively rapid calculation time allows processing and analy-
sis of the PET/MR data while the animal is still in the scan-
ner. Analysis of the processed PET/MR images of 18F-FDG
uptake within the MC-38 tumors was used to guide the next
stage of the experiment. Heterogeneous PET signal within
the tumor was verified using 1H MR spectroscopy MRS.
We used the PET signal distribution to delineate ROIs for
metabolic studies using 1H MRS PRESS with VAPOR wa-
ter suppression, spectral width 8 kHz, 900 averages with
8192 sample points, TR /TE=1685 /10 ms, 333 mm3,
TABLE I. Centroid alignment error of phantoms using the PET/MR transfor
PET/MR alignment phantom
mm Day 1 Day 1 Day 2 Day 2 Day 2
X error 0.22 0.18 0.17 0.15 0.2
Y error 0.15 0.65 0.12 0.1 0.09
Z error 0.09 0.23 0.17 0.18 0.17Medical Physics, Vol. 37, No. 5, May 2010duration=26 min. Three voxels were used for MRS imag-
ing; one in the tumor at the region of high FDG uptake, one
in the tumor at a region of low FDG uptake, and one in the
contralateral muscle. The resultant spectra were processed
and analyzed using Bruker TOPSPIN software Bruker Bio-
spin, Fremont, CA. A two-sided student’s t-test was per-
formed to compare the ratios between the high and low FDG
regions.
III. RESULTS
III.A. PET/MR image alignment
Figure 1b shows the overlay of PET and MR surface
rendering of the alignment phantom images. Slices along the
z axis in Figs. 3a and 3b show the alignment along both
the z direction and in the xy plane and demonstrate the dif-
ference in the resolution of the PET and MR images. Rods
orthogonal to the z direction span multiple slices in the PET
images. This is due to a combination of two factors. First,
because the outer diameter of the rods is 1.2 mm and the
mean positron range of the glass is 190 m annihilation
events from the 18F-FDG can occur at the outer edge of the
rod, which spans multiple image slices. Second, the spatial
resolution of the PET along the axial direction is lower than
the image slice thickness 2 mm. Table I shows the mean
and standard deviation of the centroid registration error in all
three orthogonal directions for the alignment phantom im-
FIG. 3. Different spatial resolution of the PET and MR images. a MR xy
slices of aligned phantom. b PET slices corresponding to a. Due to the
lower spatial resolution of the PET along the axial direction and the positron
range in glass matching the thickness of the capillary walls, the rod which
was mostly displayed within one slice in the MR image spans almost three
slices in the PET image. Scale bar=10 mm.
n scheme over multiple days. Units are in mm.
Figure 2d phantom
ay 3 Day 3 Mean SD Mean offset SD
0.17 0.17 0.18 0.02 0.18 0.33
0.24 0.11 0.21 0.2 0.11 0.34
0.23 0.27 0.19 0.06 0.21 0.28matio
D
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tions, registration remained consistently at subvoxel accu-
racy maximum mean alignment error=0.21 mm, voxel
size=0.2760.2760.754 mm3 and well within the reso-
lution limits of PET. This alignment procedure ably aligned
alternate second rod phantom, as shown in Figs. 2d–2f
and Table I.
Table II shows the registration error as a function of lo-
cation within the FOV. The alignment remained 0.28 mm
in accuracy throughout the whole FOV, with the mean cen-
troid registration error ranging from about 0.18 mm in the
center of the FOV to 0.28 mm at 12 mm from the center of
the FOV. One-way ANOVA analysis show no significant dif-
ference between the mean registration errors at 0, 4, 8, and
12 mm from the center of the FOV in both the x p=0.8 and
y p=0.5 directions.
We tested the alignment accuracy in vivo by imaging
small xenograft tumors. Figure 4 shows aligned mouse
PET/MR images at the level of the tumor and heart, with
high 18F-FDG uptake in both cases well within the expected
anatomical regions.
III.B. Alignment of multiple MR FOVs
Figure 5 shows the MR, PET, and overlaid PET/MR data
sets for common geometries used for PET/MR studies. In all
cases, voxel grid alignment of the aligned PET images
yielded good fit to the MR data set.
TABLE II. Centroid alignment error as a function of lo
the phantom shown in Figs. 2a–2c. ANOVA analy
racy between different locations in the field of view
in mm.
Location from ce
mm
0 4
mean SD mean
X error 0.12 0.01 0.19
Y error 0.19 0.11 0.18
FIG. 4. a PET/MR overlaid images at the level of a subcutaneous
MC38 /CEA+flank tumor showing alignment of high 18F-FDG uptake at the
tumor site. b Image volume rostral to a showing corresponding high
18F-FDG uptake at the left ventricle and aorta T=tumor, LV=left ventricle,
A=aorta, L=left, R=right, V=ventral, scale bar=6 mm.
Medical Physics, Vol. 37, No. 5, May 2010III.C. Real-time feedback studies with PET/MR allows
multimodal imaging of biological processes
Large tumors exhibit heterogeneous structures due to
many factors.28 Figure 6 shows that heterogeneous uptake of
the glyolytic marker 18F-FDG is seen within a thigh tumor.
This heterogeneity was not readily apparent in the anatomi-
cal MR image. To explore this heterogeneity, MRS was ob-
tained in ROIs guided by the variability of 18F-FDG uptake
shown in the PET images. 1H MR spectra centered in regions
of high 18F-FDG uptake in the tumor showed a higher
choline/creatine ratio compared to ROIs in low 18F-FDG ar-
eas and muscle Table III.
IV. DISCUSSION
In this study, we demonstrate the feasibility of performing
robust in vivo studies with simultaneous PET/MR imaging
using a PET insert placed in a small animal MR scanner.
Given the spatial constraints within the PET insert and ani-
mal holder, a method in lieu of the traditional fiducial marker
system is required to ensure robust registration of the two
modalities. Once the PET insert is fixed within the MR scan-
ner, the relative orientation of the PET as determined by the
n within the transaxial field of view, as measured by
howed no significant difference in registration accu-
in the x p=0.8 and y p=0.5 directions. Units are
f PET/MR FOV
8 12
mean SD mean SD
0.21 0.16 0.28 0.27
0.17 0.12 0.24 0.22
FIG. 5. PET/MR alignment using different geometries. a MR slicing of a
phantom along the coronal direction, at an oblique angle 40° on the left/
anterior plane. b MR slicing along the axial direction, rotated 30°. The
home coordinate system of the MR gradient set is noted to the left. c
FDG-PET image of a mouse tumor obtained with axial slices at a FOV
35283 mm3 smaller than FOVhome 35.3535.3525.6 mm3.
Voxel grid alignment of PET image shows intratumoral heterogeneous up-
take while accurately aligning high activity within the ureters. T=tumor,catio
sis s
both
nter o
SD
0.13
0.12U=ureters, scale bars=10 mm.
2000 Ng et al.: A robust coregistration for in vivo PET/MR 2000placement of the LSO crystal detectors and MR as deter-
mined by the placement of the imaging gradient set coordi-
nate systems is also fixed. Thus the transformation matrix
that registers images using a single alignment phantom also
brings together all subsequent PET/MR images. We confirm
this by repeatedly registering the PET and MR images of the
alignment phantom over a study session and over multiple
days with subvoxel accuracy Table I using one transform
matrix. This alignment is not dependent on the location
within the FOV Table II. Images of an alternate phantom
and tumor bearing mice also support this alignment accuracy
Fig. 4. Straightforward registration of the PET and MR
image spaces using a predetermined transformation matrix
allows for an uncomplicated multimodal imaging scheme,
whereby neither a specially designed PET/MR holder nor an
animal mold23,29 is required for image alignment. This setup
provides imaging flexibility; first, there are no potential in-
tensity spillover effects due to an external radioactive
marker, which may make low activity ROIs or ROIs close to
the marker difficult to discern. Second, this method of align-
ment allows alternate MRI transmit/receive coil setups to be
used without the need for a new alignment scheme, since the
registration is based on the spatial encoding provided solely
by MR gradient coils. This will be useful for studies that use
FIG. 6. PET guided MRS assay of MC-38 tumor. Regions of differential 18F
tumor. Spectra show differences between regions of high FDG uptake, low
TABLE III. 18FDG-PET-guided 1H MRS. FDG-PET signal from xenograft
tumors N=2 were used to guide 1H MRS in different PET signal regions.
Choline/creatine ratio were significantly different between high and low
FDG regions p=0.02.
Region Choline/creatine ratio
High FDG tumor region 3.40.4
Low FDG tumor region 1.90.3
Muscle NegligibleMedical Physics, Vol. 37, No. 5, May 2010a surface coil to achieve high SNR. Ideally, the alignment
method used should be fully automatic, although previous
reports have indicated that partial manual manipulation of
images during processing may yield sufficient alignment
accuracy.30 We adopt a manual alignment of the z direction
because of the disparate FOV sizes between the PET and MR
along that axis. As we make no prior assumption about the
physical FOV alignment along this axis, a large MR FOV is
taken to ensure full coverage of the PET FOV. From our
observations, the removal and replacement of the PET insert
within the MR scanner can cause up to 1.5 slices
1 mm displacement between the PET FOV and that of
the MRI. Studies are in progress to design a phantom align-
ment setup along the lines of previous designs for PET/CT
systems10,12,13 that will allow fully automated alignment.
Nevertheless, the general alignment strategy will remain the
same as described here regardless of the phantom setup used.
One notable difference between MR and CT acquisition is
the need to alter the imaging geometry in MR to maximize
the SNR and to obtain images at the desirable orientation or
resolution. This is especially relevant for in vivo applica-
tions; a compromise must be struck between a realistic scan
duration time and the resolution of the acquired image. In
MR-only studies, the FOV can only be determined once the
animal is loaded inside the scanner. The limited PET FOV
adds an extra geometry constraint for PET/MR studies. We
have developed a simple software GUI visualizing the over-
lay of the PET and MR FOVs to allow a quick check to
ensure that our anatomical regions of interest lie completely
in the useful PET FOV prior to image acquisition.
The constrained geometry of the PET/MR system which
limits the use of external fiducial markers and the imaging
flexibility of the MR require a robust method to coregister
PET and MR images with multiple FOV geometries. In pre-
uptake within the tumor were used to define the ROIs for 1H-MRS of the
e, and contralateral muscle. Scale bar=3 mm.-FDG
uptakvious studies, this has been addressed by making assump-
2001 Ng et al.: A robust coregistration for in vivo PET/MR 2001tions about the anatomical distribution of the functional PET
signal,31–33 using a transmission source or implanting fiducial
markers.23 The first two strategies may not yield an optimal
solution if the distribution of the PET signal is unknown or
heterogeneous, while the latter is invasive. Given the fact
that the PET is fixed physically within the MR during a
single imaging session, a simple algorithm was developed
that aligns the voxel grids of the “home” PET/MR FOV to
any alternate MR FOVs. We make the assumption here that
the MR gradients behave consistently between different
scans such that the images acquired at a set geometry in
software is the same in the hardware. Common Fourier im-
aging, as described by the k-space formalism,34 relies on spa-
tial encoding determined by spatially and temporally varying
magnetic fields created by the MR gradients. Advances in
hardware design of gradient coils35 and post-acquisition
processing36–38 means that most commercial scanners have
robust gradient performance, especially for the pulse se-
quences using Cartesian k-space trajectories see Refs. 39
and 40 for discussion of gradient coil design, specifications,
and performance. From a simultaneous PET/MR viewpoint,
the pertinent concern is that the presence of the PET insert
inside the gradient set may distort the generated gradient
fields. Previous characterization of APD-based PET inserts
has demonstrated that MR images acquired in the presence
of the PET insert show negligible geometric distortions com-
pared to those acquired without the PET18,19 see also
Supplemental Material Section I Ref. 27.
In our implementation, we transform the PET image to
match that of the MR images. We chose this approach be-
cause the resolution of the PET is lower than the MR, so
there would be less potential loss of information from image
interpolation. Also, the PET FOV is fixed and typically
smaller than the MR FOV, so this approach also simplifies
the formation of the fused data set. Other interpolation meth-
ods, apart from trilinear interpolation, can be adapted to im-
prove the quantitative value of the transformed images.41,42
However, the interpolation method we adopted should suf-
fice for PET images. Simulation of some common geom-
etries that require this schema show that the registered PET
images align well with the corresponding MR image Fig. 5.
The algorithm described is time efficient; all data sets gen-
erated took 20 min or less.
Simultaneous PET/MR imaging allows examination of
the different signals in both spatial and temporal registration.
In Fig. 6, we see heterogeneity within a tumor microenviron-
ment highlighted with both 18F-FDG PET imaging and high
resolution anatomical MRI. 1H MRS, guided by the
18F-FDG signal, confirms the heterogeneous profile of the
tumor. Rapid reconstruction, processing, and visualization of
the aligned initial PET/MR images provide the information
necessary to perform the later MRS study within the same
imaging session. Thus, obtaining feedback between the two
modalities during a single imaging session is eminently do-
able with this system. This will have multiple uses. Phantom
alignment information allows us to position the mouse to
maximize PET signal in the FOV. While new versions of the
PET insert will aim to have whole body coverage, this is
Medical Physics, Vol. 37, No. 5, May 2010typically not feasible in clinical systems or in situations
where one may want to sacrifice coverage for higher sensi-
tivity and resolution. The feedback schema can also be per-
formed during the experiment to guide study directions. The
ability to process and align the PET/MR images quickly
within an imaging session allows basic analysis of the com-
bined data set. In our study, this allowed us to determine
regions of tumor functional heterogeneity via 18F-FDG accu-
mulations and subsequently, 1H MRS studies, to assess cor-
responding heterogeneity in metabolite concentration. Again,
the external means of image registration proved useful in this
situation; no assumption of the expected distribution of the
image intensities in either image was used for alignment,
allowing us to delineate the heterogeneity within the tumor.
Although there is a correlation between the regions of high
18F-FDG uptake and high choline/creatine ratio Table III,
more studies are required to determine the significance of
this observation as the relationships between phospholipid
metabolism and glycolysis remain unclear.43–47 Further stud-
ies along these lines will involve correlating the tumor char-
acteristics such as perfusion48 and hypoxia49 with these func-
tional markers.
Simultaneous PET/MR technology has the potential to
impact both preclinical and clinical realms. The time savings
that can be obtained by doing two scans at once will facili-
tate the efficiency of longitudinal studies. Cross-modal im-
age corrections methods such as MR-guided PET motion and
attenuation correction, which rely on robust PET/MR coreg-
istration, will improve image quality and aid image
interpretation.50,51 Perhaps more importantly, like the devel-
opment of multicolor fluorescent proteins and dyes that al-
low multiple processes to be studied concurrently,52,53 simul-
taneous PET/MR will enable similar interactive studies to be
done within intact mammalian systems. Molecular imaging
agents are being developed with both PET and MR contrast
that can look at biological processes such as gene
expression,3 receptor binding,54,55 cell tracking,56 and vascu-
lar inflammation.57 Combining these agents within one study
will allow multiple physiological processes to be probed si-
multaneously.
V. CONCLUSIONS
We describe a coregistration design for performing time-
sensitive in vivo studies using a simultaneous PET/MR scan-
ner. Robust image registration between PET and MR is
shown, based on the fixed relative orientation of the PET
detectors and MR imaging gradient set. Using this setup, we
demonstrate heterogeneous metabolic activity within a tumor
using 18F-FDG PET, which was found to correlate with
choline/creatine ratios determined using MRS guided by the
18F-FDG signal levels.
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